Multimodal Clinical Study of Electroconvulsive Therapy and Magnetic Seizure Therapy
Recruiting now · Not applicable
Conditions studied: Electroconvulsive Therapy, Major Depressive Disorder, Magnetic Seizure Therapy
In brief
To compare the efficacy and tolerability of Electroconvulsive Therapy (ECT) and Magnetic Seizure Therapy (MST) in patients with major depressive disorder (MDD).
Key facts
- Study ID
- NCT07473648
- Run by
- The Second Hospital of Anhui Medical University
- People needed
- 200
- Starts
- 2025-09-01
- Expected to finish
- 2028-01-01
- Last updated by the study team
- 2026-07-17
Who can join
Age: 12 and older, up to 80. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Aged 12-80 years;
- Diagnosis confirmed by two psychiatrists per DSM-5;
- Stable medication regimen pre-enrollment;
- Indicated for neuromodulation OR with visual field defects.
You may not qualify if…
- Major systemic diseases;
- Prior neuromodulation within 3 months;
- Pregnancy or potential pregnancy;
- Metal implants or claustrophobia.
Where it is running
- Anhui Medical University — Hefei, Anhui, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.